Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study.
about
Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Bevacizumab based chemotherapy ...... rvational institutional study.
@ast
Bevacizumab based chemotherapy ...... rvational institutional study.
@en
Bevacizumab based chemotherapy ...... rvational institutional study.
@nl
type
label
Bevacizumab based chemotherapy ...... rvational institutional study.
@ast
Bevacizumab based chemotherapy ...... rvational institutional study.
@en
Bevacizumab based chemotherapy ...... rvational institutional study.
@nl
prefLabel
Bevacizumab based chemotherapy ...... rvational institutional study.
@ast
Bevacizumab based chemotherapy ...... rvational institutional study.
@en
Bevacizumab based chemotherapy ...... rvational institutional study.
@nl
P2093
P2860
P356
P1433
P1476
Bevacizumab based chemotherapy ...... rvational institutional study.
@en
P2093
Hassan Errihani
Lamiaa Boulaamane
Saber Boutayeb
P2860
P2888
P356
10.1186/1756-0500-5-162
P577
2012-03-22T00:00:00Z
P5875
P6179
1052378955